Endoscopic Cryotherapy for the Treatment of Epistaxis Due to Hereditary Hemorrhagic Telangiectasia

被引:5
|
作者
Kim, Joo Yeon [1 ]
Oh, Jung Ho [1 ]
Kim, Geun Tae [2 ]
Kwon, Jae Hwan [1 ]
机构
[1] Kosin Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Pusan 602702, South Korea
[2] Kosin Univ, Coll Med, Div Rheumatol, Pusan 602702, South Korea
关键词
Hereditary hemorrhagic telangiectasia; HHT; cryotherapy; POPULATION; MANAGEMENT;
D O I
10.1097/SCS.0000000000000453
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant vascular disease, involves mainly skin, mucocutaneous membranes, and viscera. Epistaxis is one of the most common symptoms of HHT, and chronic, frequently relapsing epistaxis can cause symptoms such as iron deficiency anemia, severe crusting, and nasal obstruction that can cause lower quality of life. Treatments for HHT range from medication and conservative management to more aggressive surgeries. None of the treatment options, however, have had satisfactory outcomes until now. We introduced cryotherapy for a patient with HHT and at least a 10-year history of frequent, severe epistaxis. This treatment strategy resulted in successful management of symptoms and no associated complications. We present herein a literature review and the clinical course and symptoms of an HHT patient who underwent cryotherapy.
引用
收藏
页码:E120 / E122
页数:3
相关论文
共 50 条
  • [1] EPISTAXIS DUE TO HEREDITARY HEMORRHAGIC TELANGIECTASIA
    ZOHAR, Y
    STRAUSS, M
    LARYNGOSCOPE, 1995, 105 (04): : 445 - 446
  • [2] EPISTAXIS DUE TO HEREDITARY HEMORRHAGIC TELANGIECTASIA - REPLY
    GLUCKMAN, JL
    LARYNGOSCOPE, 1995, 105 (04): : 446 - 446
  • [3] Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis
    Sautter, Nathan B.
    Smith, Timothy L.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2016, 49 (03) : 639 - +
  • [4] A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia
    Lund, VJ
    Howard, DJ
    AMERICAN JOURNAL OF RHINOLOGY, 1999, 13 (04): : 319 - 322
  • [5] Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
    Layton, K. F.
    Kallmes, D. F.
    Gray, L. A.
    Cloft, H. J.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2007, 28 (05) : 885 - 888
  • [6] Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia
    Olitsky, Scott E.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (03) : 375 - 376
  • [7] Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Hemorrhagic Telangiectasia
    Donato, Mariana
    Pimentel, Joao
    Cabral, Rui
    Escada, Pedro
    ACTA MEDICA PORTUGUESA, 2018, 31 (01): : 63 - 66
  • [8] The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia
    Hitchings, AE
    Lennox, PA
    Lund, VJ
    Howard, DJ
    AMERICAN JOURNAL OF RHINOLOGY, 2005, 19 (01): : 75 - 78
  • [9] Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia
    Al-Samkari, Hanny
    Kasthuri, Raj S.
    Iyer, Vivek N.
    Pishko, Allyson M.
    Decker, Jake E.
    Weiss, Clifford R.
    Whitehead, Kevin J.
    Conrad, Miles B.
    Zumberg, Marc S.
    Zhou, Jenny Y.
    Parambil, Joseph
    Marsh, Derek
    Clancy, Marianne
    Bradley, Lauren
    Wisniewski, Lisa
    Carper, Benjamin A.
    Thomas, Sonia M.
    McCrae, Keith R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (11): : 1015 - 1027
  • [10] Cauterization for epistaxis in hereditary hemorrhagic telangiectasia
    Dabiri, J.
    Fakhoury, R.
    Choufani, G.
    Mine, B.
    Hassid, S.
    B-ENT, 2016, 12 (01): : 9 - 16